SCHEMBL1696099

SCHEMBL1696099

CCc1cccc(NC(C(=O)OC2CN3CCC2CC3)c2ccc(OC)nc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 10/20 0.46
PDE4B Q07343 4/20 0.46
PDE2A O00408 3/20 0.46
PDE6D O43924 3/20 0.46
PDE8A O60658 3/20 0.46
PDE5A O76074 3/20 0.46
PDE9A O76083 3/20 0.46
PDE8B O95263 3/20 0.46
PDE6A P16499 3/20 0.46
PDE6G P18545 3/20 0.46
PDE4A P27815 3/20 0.46
PDE6B P35913 3/20 0.46
PDE6C P51160 3/20 0.46
PDE1A P54750 3/20 0.46
PDE1B Q01064 3/20 0.46
PDE4C Q08493 3/20 0.46
PDE4D Q08499 3/20 0.46
PDE3B Q13370 3/20 0.46
PDE7A Q13946 3/20 0.46
PDE6H Q13956 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16476741 1.00 CHRM3 (0.46) CHRM3PDE4BPDE2APDE6DPDE8A
SCHEMBL1696092 1.00 CHRM3 (0.46) CHRM3PDE4BPDE2APDE6DPDE8A
SCHEMBL1696249 0.89 CHRM3 (0.51) CHRM3PDE4BPDE2APDE6DPDE8A
SCHEMBL16463343 0.89 CHRM3 (0.51) CHRM3PDE4BPDE2APDE6DPDE8A
SCHEMBL1696197 0.89 CHRNA7 (0.48) CHRM3PDE4BPDE2APDE6DPDE8A
SCHEMBL16476688 0.89 CHRNA7 (0.48) CHRM3PDE4BPDE2APDE6DPDE8A
SCHEMBL1696195 0.89 CHRNA7 (0.48) CHRM3PDE4BPDE2APDE6DPDE8A
SCHEMBL1696156 0.88 CHRM3 (0.44) CHRM3PDE4BPDE2APDE6DPDE8A
SCHEMBL1696161 0.88 CHRM3 (0.44) CHRM3PDE4BPDE2APDE6DPDE8A
SCHEMBL16476743 0.88 CHRM3 (0.44) CHRM3PDE4BPDE2APDE6DPDE8A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2585457-B1 Alkaloid aminoester derivatives and medicinal composition thereof CHIESI FARMA SPA (IT) 2015-07-22 EP disclosed
US-8629160-B2 Alkaloid aminoester derivatives and medicinal composition thereof CHIESI FARMACEUTICI S.P.A. (IT) 2014-01-14 US disclosed
EP-2585457-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF Chiesi Farmaceutici S.p.A. (IT) 2013-05-01 EP disclosed
WO-2011160918-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2011-12-29 WO disclosed
US-20110311461-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2011-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110311461-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHRM3, CHRM2, CHRM5 CHRM3 1/4885PDE4B 224/4885PDE2A 283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.